COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,832 Articles (22,553 medRxiv, 8,279 bioRxiv)

Most recent first Previous |  Page 1652: Articles 16511-16520  | Next

Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern
Lien, C.-E., Kuo, T.-Y., Lin, Y.-J., Lian, W.-C., Lin, M.-Y., Liu, L. T. C., Chou, Y.-C., Chen, C.
10.1101/2021.03.19.21254000 — Posted: 2021-03-22
Older biological age is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank
Wang, Q., Codd, V., Raisi-Estabragh, Z., Musicha, C., Vasiliki, B., Kaptoge, S., Allara, E., Di Angelantonio, E., Butterworth, A. S., Wood, A. M., Thompson, J. R., Petersen, S. E., Harvey, N. C., Danesh, J. N., Samani, N. J., Nelson, C. P.
10.1101/2021.03.20.21254010 — Posted: 2021-03-22
Weekly SARS-CoV-2 screening of asymptomatic students and staff to guide and evaluate strategies for safer in-person learning
Doron, S., Ingalls, R., Beauchamp, A., Boehm, J., Boucher, H., Chow, L., Corridan, L., Goehringer, C., Golenbock, D., Larsen, L., Lussier, D., Testa, M., Ciaranello, A. L.
10.1101/2021.03.20.21253976 — Posted: 2021-03-22
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
Elyanow, R., Snyder, T. M., Dalai, S. C., Gittelman, R. M., Boonyaratanakornkit, J., Wald, A., Selke, S., Wener, M. H., Morishima, C., Greninger, A. L., Holbrook, M. R., Kaplan, I. M., Zahid, H. J., Carlson, J. M., Baldo, L., Manley, T., Robins, H. S., Koelle, D. M.
10.1101/2021.03.19.21251426 — Posted: 2021-03-22
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Kunze, K. L., Johnson, P. W., van Helmond, N., Senefeld, J. W., Petersen, M. M., Klassen, S. A., Wiggins, C. C., Klompas, A. M., Bruno, K. A., Mills, J. R., Theel, E. S., Buras, M. R., Golafshar, M. A., Sexton, M. A., Diaz Soto, J. C., Baker, S. E., Shepherd, J. R. A., Verdun, N. C., Marks, P., Paneth, N. S., Fairweather, D., Wright, R. S., van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Rea, R. F., Herasevich, V., Whelan, E. R., Clayburn, A. J., Larson, K. F., Ripoll, J. G., Andersen, K. J., Lesser, E. R., Vogt, M. N. P., Dennis, J. J., Regimbal, R. J., Bauer, P. R., Blair, J. E., Casadevall, A., Carter, R. E., Joyner, M. J.
10.1101/2021.03.19.21253975 — Posted: 2021-03-22
The Impact of Early or Late Lockdowns on the Spread of COVID-19 in US Counties
Huang, X., Shao, X., Xing, L., Hu, Y., Sin, D., Zhang, X.
10.1101/2021.03.19.21253997 — Posted: 2021-03-22
Acriflavine, a clinically aproved drug, inhibits SARS-CoV-2 and other betacoronaviruses
Napolitano, V., Dabrowska, A., Schorpp, K., Mourao, A., Barreto-Duran, E., Benedyk, M., Botwina, P., Brandner, S., Bostock, M., Chykunova, Y., Czarna, A., Dubin, G., Frohlich, T., Hoelscher, M., Jedrysik, M., Matsuda, A., Owczarek, K., Pachota, M., Plettenburg, O., Potempa, J., Rothenaigner, I., Schlauderer, F., Szczepanski, A., Mohn, K. G.-I., Blomberg, B., Sattler, M., Hadian, K., Popowicz, G. M., Pyrc, K.
10.1101/2021.03.20.436259 — Posted: 2021-03-21
Structural and energetic profiling of SARS-CoV-2 antibody recognition and the impact of circulating variants
Yin, R., Guest, J. D., Taherzadeh, G., Gowthaman, R., Mittra, I., Quackenbush, J., Pierce, B. G.
10.1101/2021.03.21.436311 — Posted: 2021-03-21
Critical interactions for SARS-CoV-2 spike protein binding to ACE2 identified by machine learning
Pavlova, A., Zhang, Z., Acharya, A., Lynch, D. L., Pang, Y. T., Mou, Z., Parks, J. M., Chipot, C., Gumbart, J. C.
10.1101/2021.03.19.436231 — Posted: 2021-03-21
Circadian regulation of SARS-CoV-2 infection in lung epithelial cells
Zhuang, X., Tsukuda, S., Wrensch, F., Wing, P. A., Borrmann, H., Harris, J. M., Morgan, S. B., Mailly, L., Thakur, N., Conceicao, C., Sanghani, H., Heydmann, L., Bach, C., Ashton, A., Walsh, S., Tan, T. K., Schimanski, L., Huang, K.-Y. A., Schuster, C., Watashi, K., Hinks, T. S., Jagannath, A., Vausdevan, S. R., Bailey, D., Baumert, T. F., McKeating, J. A.
10.1101/2021.03.20.436163 — Posted: 2021-03-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).